60483_BioElectronis.jpg
BioElectronics President’s Response to Stock Price Decline
December 04, 2018 08:30 ET | BioElectronics Corporation
Frederick, Maryland, Dec. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Dear Fellow Shareholders, While we were all disappointed by the dramatic drop in the stock price, it hasn’t had an...
60483_BioElectronis.jpg
BioElectronics Announces FDA Market Clearance Update
November 27, 2018 09:31 ET | BioElectronics Corporation
FREDERICK, MD, Nov. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC Pink: BIEL), the maker of non-invasive electroceutical devices, announced that the U.S. Food...
60483_BioElectronis.jpg
BioElectronics Signs a Five Country Additional Distribution Agreement with Mundipharma Pty Limited, South East Asia
November 15, 2018 08:30 ET | BioElectronics Corporation
FREDERICK, MD, Nov. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that Mundipharma Pty Limited, has added the...
60483_BioElectronis.jpg
BioElectronics Announces Publication of Electroceuticals Article on Chronic Pain
October 04, 2018 08:30 ET | BioElectronics Corporation
FREDERICK, MD, Oct. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC Pink: BIEL), the maker of non-invasive electroceutical devices, announced the publication of an...
60483_BioElectronis.jpg
BioElectronics Applies for FDA’s Opioid Alternative Innovation Challenge Program
August 13, 2018 07:30 ET | BioElectronics Corporation
FREDERICK, MD, Aug. 13, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, is pleased to announce that it has submitted an application to the U.S. Food and Drug...
60483_BioElectronis.jpg
BioElectronics ActiPatch Musculoskeletal Therapy Added to Mundipharma Australia's Pain Portfolio
July 23, 2018 08:30 ET | BioElectronics Corporation
FREDERICK, MD, July 23, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that Mundipharma Pty Limited (Mundipharma),...
60483_BioElectronis.jpg
BioElectronics Files FDA Application for Treatment of Musculoskeletal Pain
July 12, 2018 08:30 ET | BioElectronics Corporation
FREDERICK, MD, July 12, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that a Traditional 510(k) Premarket Notification for ActiPatch®...
60483_BioElectronis.jpg
B. Braun Medical Includes BioElectronics ActiPatch Medical Device In Its Same Day Knee and Hip Surgical Program
May 31, 2018 08:00 ET | BioElectronics Corporation
FREDERICK, MD., May 31, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), maker of advanced medical devices announces that B. Braun Ltd, of Sheffield, UK has recently completed...
60483_BioElectronis.jpg
BioElectronics Receives FDA Pre-Submission Approval for its Post-Operation Pain Market Clearance Application
May 29, 2018 11:48 ET | BioElectronics Corporation
FREDERICK, MD, May 29, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com reports that it has cancelled today’s scheduled US Food and Drug Administration meeting....
60483_BioElectronis.jpg
BioElectronics Receives FDA Pre-Submission Approval for its Relief of Musculoskeletal Pain Market Clearance Application
May 11, 2018 08:30 ET | BioElectronics Corporation
FREDERICK, MD , May 11, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to report on the outcome of its Pre-Submission meeting on May 9th, 2018 with...